The Gerontologist
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fillenbaum, G. G.
Right arrow Articles by Taylor, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fillenbaum, G. G.
Right arrow Articles by Taylor, D. H., Jr.
The Gerontologist 42:381-386 (2002)
© 2002 The Gerontological Society of America

Apolipoprotein E {varepsilon}4 and Risk of Mortality in African American and White Older Community Residents

Gerda G. Fillenbaum, PhDa, Dan G. Blazer, MD, PhDb, Bruce M. Burchett, PhD, JDa, Ann M. Saunders, PhDc and Donald H. Taylor, Jr., PhDd

a Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC
b Department of Psychiatry and Behavioral Sciences, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC
c Division of Neurology, Department of Medicine, Duke University Medical Center, Durham, NC
d Center for Health Policy/Law and Management, Duke University Medical Center, Durham, NC

Correspondence: Gerda G. Fillenbaum, PhD, Center for the Study of Aging and Human Development, Duke University Medical Center, Box 3003, Durham, NC 27710. E-mail: ggf{at}geri.duke.edu.

Decision Editor: Laurence G. Branch, PhD

Purpose: The goal of this study was to determine whether the {varepsilon}4 allele of apolipoprotein E is predictive of mortality in a community-based sample. Design and Methods: Of the stratified random household sample of 4,162 participants age 65 years and older enrolled in the Duke site of the Established Populations for Epidemiologic Studies of the Elderly, those included in the present study were the 1,998 who were genotyped for apolipoprotein E (alleles {varepsilon}2, {varepsilon}3, and {varepsilon}4) six years after baseline, and for whom survival status eight years later was known by search of the National Death Index. Information on demographic characteristics, physical and mental health status, functional status, and health services use was determined by structured questionnaires administered in person in the home. Results: The {varepsilon}4 allele did not predict mortality for the group as a whole, or for those who were cognitively impaired. It did predict mortality for those who reported having had a heart attack or stroke. Implications: The apolipoprotein {varepsilon}4 allele—although a risk factor for Alzheimer's disease, heart disease, and stroke—was only found to be a risk factor for mortality for those community residents who had had a heart attack or stroke. Otherwise, for this community-based sample, 71 years of age and older, it did not predict time to death and was not a risk factor for mortality.

Key Words: Apolipoprotein E • Mortality • Race • African American • White




This article has been cited by other articles:


Home page
Age AgeingHome page
A. Kulminski, S. V. Ukraintseva, K. G. Arbeev, K. G. Manton, J. Oshima, G. M. Martin, and A. I. Yashin
Association between APOE {varepsilon}2/{varepsilon}3/{varepsilon}4 polymorphism and disability severity in a national long-term care survey sample
Age Ageing, May 1, 2008; 37(3): 288 - 293.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
D. C. Ewbank
Differences in the Association Between Apolipoprotein E Genotype and Mortality Across Populations
J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2007; 62(8): 899 - 907.
[Abstract] [Full Text] [PDF]


Home page
Journal of Applied GerontologyHome page
J. C. Hays, B. M. Burchett, G. G. Fillenbaum, and D. G. Blazer
Is the APOE {epsilon}4 Allele a Risk to Person-Environment Fit?
Journal of Applied Gerontology, September 1, 2004; 23(3): 247 - 265.
[Abstract] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
D. C. Ewbank
The APOE Gene and Differences in Life Expectancy in Europe
J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2004; 59(1): B16 - 20.
[Abstract] [Full Text] [PDF]


Home page
J Aging HealthHome page
D. G. Blazer, G. G. Fillenbaum, D. T. Gold, B. M. Burchett, and J. C. Hays
Apoe {epsilon}4 as a Predictor of Subjective Quality of Life in a Biracial Older Person Community Sample
J Aging Health, November 1, 2003; 15(4): 645 - 660.
[Abstract] [PDF]


Home page
AJGPHome page
D. H. Taylor Jr., G. Fillenbaum, B. Burchett, and D. G. Blazer
Is the APOE {epsilon}4 Genotype Associated With Higher Hospital Costs Among Elderly Patients?
Am J Geriatr Psychiatry, February 1, 2003; 11(1): 75 - 82.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals Journals of Gerontology Series A: Biological Sciences and Medical Sciences Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 2002 by The Gerontological Society of America.